Potential utility of PPARgamma agonists in targeting chronic myeloid leukemia stem cells. Atef B, El-Ashwah S, Saleh LM, Gawish H, et al. Ann Hematol 2026;105:136.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Atef B, El-Ashwah S, Saleh LM, Gawish H, et al. Potential utility of PPARgamma agonists in targeting chronic myeloid leukemia stem cells. Ann Hematol 2026;105:136.
PMID: 41735647